Robert J Kinders Selected Research

Robert J Kinders Research Topics

Disease

45	Neoplasms (Cancer) 01/2021 - 11/2008
5	Circulating Neoplastic Cells 01/2020 - 02/2010
4	Carcinoma (Carcinomatosis) 01/2020 - 01/2015
4	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 03/2012
4	Hypoxia (Hypoxemia) 08/2014 - 07/2009
3	Lymphoma (Lymphomas) 11/2020 - 03/2012
3	Triple Negative Breast Neoplasms 01/2018 - 03/2012
2	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2018
2	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 06/2015
2	Peritoneal Neoplasms 01/2017 - 01/2015
2	Fallopian Tube Neoplasms 01/2017 - 04/2015
2	Carcinogenesis 08/2015 - 01/2011
1	Endometrial Neoplasms (Endometrial Cancer) 01/2021
1	Breast Neoplasms (Breast Cancer) 01/2020
1	Prostatic Neoplasms (Prostate Cancer) 01/2020
1	Diarrhea 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	Stomach Neoplasms (Stomach Cancer) 01/2018
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018
1	Leukemia 02/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 02/2017
1	Mucositis 02/2017
1	Fanconi Anemia (Fanconi's Anemia) 02/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 02/2017
1	Fatigue 01/2017
1	Lymphopenia (Lymphocytopenia) 02/2016
1	Ovarian Epithelial Carcinoma 02/2016

Drug/Important Bio-Agent (IBA)

11	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020 - 09/2010
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 07/2009
10	veliparibIBA 02/2017 - 11/2008
9	Proteins (Proteins, Gene)FDA Link 11/2020 - 02/2014
9	Pharmaceutical PreparationsIBA 12/2018 - 02/2010
7	Topotecan (Hycamtin)FDA LinkGeneric 03/2018 - 07/2009
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 09/2010
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2016 - 11/2008
4	Histones (Histone)IBA 02/2017 - 10/2015
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2016 - 03/2012
3	birinapantIBA 03/2018 - 02/2016
3	Phosphotransferases (Kinase)IBA 01/2018 - 04/2013
3	Poly Adenosine Diphosphate RiboseIBA 01/2016 - 01/2011
3	EnzymesIBA 08/2014 - 07/2009
2	Messenger RNA (mRNA)IBA 01/2021 - 02/2014
2	adavosertibIBA 01/2021 - 10/2015
2	Temozolomide (Temodar)FDA LinkGeneric 11/2020 - 02/2017
2	NSC 724998IBA 12/2018 - 07/2016
2	Topoisomerase I InhibitorsIBA 12/2018 - 03/2018
2	PlatinumIBA 01/2018 - 02/2016
2	AntibodiesIBA 01/2018 - 01/2016
2	Indicators and Reagents (Reagents)IBA 01/2018 - 01/2016
2	Bevacizumab (Avastin)FDA Link 04/2014 - 07/2009
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2012 - 07/2009
2	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2011 - 09/2010
1	RNA (Ribonucleic Acid)IBA 01/2021
1	2'-deoxy-4'-thiocytidineIBA 01/2021
1	Tyrosine (L-Tyrosine)FDA Link 01/2021
1	methoxyamineIBA 11/2020
1	Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA 01/2020
1	nilotinib FDA Link 01/2020
1	CateninsIBA 01/2020
1	TubulinIBA 01/2020
1	VimentinIBA 01/2020
1	talazoparibIBA 01/2020
1	Tyrosine Kinase InhibitorsIBA 01/2020
1	TetrahydrouridineIBA 01/2020
1	5-fluoro-2'-deoxycytidineIBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	MethyltransferasesIBA 01/2020
1	Cyclin-Dependent Kinase Inhibitor p16IBA 01/2020
1	pazopanib FDA Link 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Biological ProductsIBA 01/2019
1	CamptothecinIBA 12/2018
1	indimitecanIBA 12/2018
1	ParaffinIBA 03/2018
1	Cisplatin (Platino)FDA LinkGeneric 03/2018
1	Formaldehyde (Formol)FDA Link 03/2018
1	tepotinibIBA 01/2018
1	GSK 1363089IBA 01/2018
1	ARQ 197IBA 01/2018
1	cabozantinibIBA 01/2018
1	EMD1214063IBA 01/2018
1	defactinibIBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2018
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 02/2017
1	Poly (ADP-Ribose) Polymerase-1IBA 02/2017
1	Membrane Proteins (Integral Membrane Proteins)IBA 02/2016
1	Caspase 3 (Caspase-3)IBA 02/2016
1	Baculoviral IAP Repeat-Containing 3 ProteinIBA 02/2016
1	DNA Repair EnzymesIBA 01/2016
1	Epithelial Cell Adhesion MoleculeIBA 01/2016
1	5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- oneIBA 01/2016
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2016
1	Differentiation AntigensIBA 01/2016

Therapy/Procedure

10	Therapeutics 11/2020 - 07/2009
2	Radiotherapy 01/2017 - 01/2015
2	Oral Administration 06/2015 - 03/2012
1	Aftercare (After-Treatment) 12/2018
1	Drug Therapy (Chemotherapy) 01/2016